一、募集资金基本情况 证券代码：002980 证券简称：华盛昌 公告编号：2025-033 深圳市华盛昌科技实业股份有限公司 2025 年半年度募集资金存放与使用情况的专项报告 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 根据《深圳证券交易所上市公司自律监管指引第1号——主板上市公司规范 运作》和相关格式指引的规定，深圳市华盛昌科技实业股份有限公司（以下简称 "公司"）现将2025年半年度募集资金存放与使用情况的专项报告如下： （一）募集资金到位情况 经中国证券监督管理委员会《关于核准深圳市华盛昌科技实业股份有限公司 首次公开发行股票的批复》（证监许可[2020]463号）核准，公司首次公开发行 人民币普通股（A股）3,333.34万股，每股面值为人民币1.00元，每股发行价格为 人民币14.89元，本次公司发行股票募集资金总额为496,334,326.00元，扣除承销 费用、保荐费用以及相关发行费用42,067,924.49元后，实际募集资金净额为 454,266,401.51元。上述募集资金已于2020年4月7日到位，大华会计师事务所（特 殊普通合 ...

深圳市华盛昌科技实业股份有限公司 2025 年半年度财务报告 2025 年 08 月 | 财务报表附注 18 | | --- | 深圳市华盛昌科技实业股份有限公司 2025 年半年度财务报告 合并资产负债表 2025 年 6 月 30 日 编制单位：深圳市华盛昌科技实业股份有限公司 单位：人民币元 | 项目 | 2025 年 6 月 30 日 | 2025 年 1 月 1 日 | | --- | --- | --- | | 流动资产： | | | | 货币资金 | 216,591,605.92 | 237,395,625.09 | | 结算备付金 | | | | 拆出资金 | | | | 交易性金融资产 | 168,105,935.18 | 228,885,280.59 | | 衍生金融资产 | | | | 应收票据 | | | | 应收账款 | 145,129,469.45 | 198,843,321.04 | | 应收款项融资 | 280,238.00 | 424,632.00 | | 预付款项 | 28,805,809.08 | 16,529,253.85 | | 应收保费 | | | | 应收分保账款 ...

一、监事会会议召开情况 证券代码：002980 证券简称：华盛昌 公告编号：2025-031 深圳市华盛昌科技实业股份有限公司 第三届监事会 2025 年第二次会议决议公告 本公司及公司全体监事会成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 具体内容详见公司在巨潮资讯网（www.cninfo.com.cn）披露的《2025年半年 度报告》全文及在《证券时报》、《中国证券报》、《上海证券报》和巨潮资讯网 （www.cninfo.com.cn）披露的《2025年半年度报告摘要》。 深圳市华盛昌科技实业股份有限公司（以下简称"公司"）第三届监事会2025 年第二次会议通知于2025年8月12日以电子邮件等方式发出，并于2025年8月22 日下午16:00以通讯方式召开。会议应出席监事3人，实际出席监事3人，均以通 讯表决方式出席会议，会议由监事会主席钟孝条先生主持。本次会议的召开，符 合《中华人民共和国公司法》、《中华人民共和国证券法》的相关规定。 二、监事会会议审议情况 经与会监事充分讨论与表决，通过了以下议案： 1、审议通过了《关于公司2025年半年度报告全文及其摘要的议案》 ...

证券代码：002980 证券简称：华盛昌 公告编号：2025-030 深圳市华盛昌科技实业股份有限公司 第三届董事会 2025 年第四次会议决议公告 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 表决结果为：8 票同意，0 票反对，0 票弃权。 董事会审计委员会审议通过该议案。 2、审议通过了《关于2025年半年度募集资金存放与使用情况的专项报告的 议案》 具体内容详见公司在《证券时报》、《中国证券报》、《上海证券报》和巨 潮资讯网（www.cninfo.com.cn）披露的《2025 年半年度募集资金存放与使用情 况的专项报告》。 表决结果为：8 票同意，0 票反对，0 票弃权。 董事会审计委员会审议通过该议案。 深圳市华盛昌科技实业股份有限公司（以下简称"公司"）第三届董事会 2025 年第四次会议通知于 2025 年 8 月 12 日以电子邮件、微信等方式发出，并 于 2025 年 8 月 22 日下午 15:00 以通讯方式召开。会议应出席董事 8 人，实际出 席董事 8 人，均以通讯表决方式出席会议，会议由董事长袁剑敏先 ...

[Important Notes, Table of Contents, and Definitions](index=2&type=section&id=%E7%AC%AC%E4%B8%80%E8%8A%82%20%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA%E3%80%81%E7%9B%AE%E5%BD%95%E5%92%8C%E9%87%8A%E4%B9%89) This section provides essential disclaimers, lists reference documents, and defines key terms used throughout the report [Important Notes](index=2&type=section&id=%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA) The Board of Directors, Supervisory Board, and senior management guarantee the truthfulness, accuracy, and completeness of the semi-annual report, assuming legal responsibility - The company's Board of Directors, Supervisory Board, and senior management guarantee the truthfulness, accuracy, and completeness of the semi-annual report, free from false statements, misleading representations, or major omissions, and assume individual and joint legal responsibility[3](index=3&type=chunk) - Company principal Yuan Jianmin, head of accounting Liu Haiqin, and head of accounting department Chen Lijuan declare that the financial report in this semi-annual report is true, accurate, and complete[3](index=3&type=chunk) - The company plans not to distribute cash dividends, bonus shares, or convert capital reserves into share capital[4](index=4&type=chunk) [Catalogue of Reference Documents](index=4&type=section&id=%E5%A4%87%E6%9F%A5%E6%96%87%E4%BB%B6%E7%9B%AE%E5%BD%95) This section lists the company's semi-annual report reference documents, including signed financial statements and publicly disclosed company files - Reference documents include financial statements signed and sealed by the company principal, head of accounting, and head of accounting department[8](index=8&type=chunk) - Reference documents include originals of all company files and announcements publicly disclosed on the CSRC-designated website during the reporting period[8](index=8&type=chunk) - Reference documents include the signed and sealed 2025 semi-annual report summary and full text by the company's legal representative[8](index=8&type=chunk) [Definitions](index=5&type=section&id=%E9%87%8A%E4%B9%89) This section defines common terms and company entities for the reporting period, from January 1 to June 30, 2025 - The reporting period refers to January 1, 2025, to June 30, 2025[9](index=9&type=chunk) - Huashengchang, the Company, or this Company refers to Shenzhen Everbest Machinery Industry Co., Ltd[9](index=9&type=chunk) - Lists the company's main subsidiaries and partnerships, including Huaju Enterprise, Huahang Enterprise, Zhiyi Investment, Huazhihui, Beijing Xinxiang, Shanghai Kaiyu, Bazhong Zhuochuang, Huizhou Huashengchang, Huashengchang Software, Xi'an Haige, Shanghai Huashengchang, Huashengchang Biomedical, Shendu Gancce, Shenjing Zhinen, Huashengchang New Energy, Jiangxi Huashengchang, Hong Kong Huashengchang, Russia Huashengchang, Germany Huashengchang, Chuangte Technology Co., Ltd., Vietnam Huashengchang, and Uzbekistan Huashengchang[9](index=9&type=chunk) [Company Profile and Key Financial Indicators](index=6&type=section&id=%E7%AC%AC%E4%BA%8C%E8%8A%82%20%E5%85%AC%E5%8F%B8%E7%AE%80%E4%BB%8B%E5%92%8C%E4%B8%BB%E8%A6%81%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) This section provides an overview of the company's basic information, contact details, and key financial performance metrics for the reporting period [Company Profile](index=6&type=section&id=%E4%B8%80%E3%80%81%E5%85%AC%E5%8F%B8%E7%AE%80%E4%BB%8B) This section provides the company's basic information, including stock ticker, code, exchange, names, and legal representative Company Basic Information | Indicator | Content | | :--- | :--- | | Stock Abbreviation | Huashengchang | | Stock Code | 002980 | | Stock Exchange | Shenzhen Stock Exchange | | Chinese Name | Shenzhen Everbest Machinery Industry Co., Ltd. | | Foreign Name | Shenzhen Everbest Machinery Industry Co., Ltd. | | Legal Representative | Yuan Jianmin | [Contact Persons and Contact Information](index=6&type=section&id=%E4%BA%8C%E3%80%81%E8%81%94%E7%B3%BB%E4%BA%BA%E5%92%8C%E8%81%94%E7%B3%BB%E6%96%B9%E5%BC%8F) This section provides contact information for the company's Board Secretary and Securities Affairs Representative Company Contact Information | Position | Name | Contact Address | Phone | Fax | Email | | :--- | :--- | :--- | :--- | :--- | :--- | | Board Secretary | Ji Hong | Building 19, Block 5, Baiwangxin Industrial Park, Songbai Road, Baimang, Xili, Nanshan District, Shenzhen | 0755-27353188 | 0755-27652253 | jihong@cem-instruments.com | | Securities Affairs Representative | Chen Biying | Building 19, Block 5, Baiwangxin Industrial Park, Songbai Road, Baimang, Xili, Nanshan District, Shenzhen | 0755-27353188 | 0755-27652253 | chenbiying@cem-instruments.com | [Other Information](index=6&type=section&id=%E4%B8%89%E3%80%81%E5%85%B6%E4%BB%96%E6%83%85%E5%86%B5) This section states that the company's contact information, disclosure, and document storage locations remained unchanged during the reporting period - The company's registered address, office address, postal code, website, and email address remained unchanged during the reporting period, as detailed in the 2024 annual report[13](index=13&type=chunk) - The securities exchange website and media names/URLs for the company's semi-annual report disclosure, and the report's storage location, remained unchanged during the reporting period, as detailed in the 2024 annual report[14](index=14&type=chunk) [Key Accounting Data and Financial Indicators](index=7&type=section&id=%E5%9B%9B%E3%80%81%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) This section presents the company's key accounting data and financial indicators for H1 2025, showing revenue growth but a significant decline in net profit attributable to shareholders Key Accounting Data and Financial Indicators (Current Period vs. Prior Year) | Indicator | Current Period (CNY) | Prior Year (CNY) | YoY Change | | :--- | :--- | :--- | :--- | | Operating Revenue | 349,399,360.85 | 333,050,691.77 | 4.91% | | Net Profit Attributable to Shareholders of Listed Company | 43,473,946.64 | 64,196,502.47 | -32.28% | | Net Profit Attributable to Shareholders of Listed Company (Excluding Non-recurring Gains/Losses) | 41,218,087.74 | 59,927,469.34 | -31.22% | | Net Cash Flow from Operating Activities | 74,890,850.46 | 83,197,996.78 | -9.98% | | Basic Earnings Per Share (CNY/share) | 0.23 | 0.47 | -51.06% | | Diluted Earnings Per Share (CNY/share) | 0.23 | 0.47 | -51.06% | | Weighted Average Return on Net Assets | 3.89% | 5.97% | -2.08% | Key Accounting Data and Financial Indicators (Current Period End vs. Prior Year End) | Indicator | Current Period End (CNY) | Prior Year End (CNY) | Change from Prior Year End | | :--- | :--- | :--- | :--- | | Total Assets | 1,436,424,433.86 | 1,521,375,238.03 | -5.58% | | Net Assets Attributable to Shareholders of Listed Company | 1,057,748,477.92 | 1,094,647,789.16 | -3.37% | - Net profit after deducting the impact of share-based payments was **CNY 60,517,093.21**[16](index=16&type=chunk) [Differences in Accounting Data under Domestic and International Accounting Standards](index=7&type=section&id=%E4%BA%94%E3%80%81%E5%A2%83%E5%86%85%E5%A4%96%E4%BC%9A%E8%AE%A1%E5%87%86%E5%88%99%E4%B8%8B%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%B7%AE%E5%BC%82) This section states no differences exist in net profit and net assets between financial reports disclosed under international/overseas accounting standards and Chinese accounting standards - During the reporting period, there were no differences in net profit and net assets between financial reports disclosed under International Accounting Standards and Chinese Accounting Standards[17](index=17&type=chunk) - During the reporting period, there were no differences in net profit and net assets between financial reports disclosed under overseas accounting standards and Chinese Accounting Standards[18](index=18&type=chunk) [Non-recurring Gains and Losses and Amounts](index=7&type=section&id=%E5%85%AD%E3%80%81%E9%9D%9E%E7%BB%8F%E5%B8%B8%E6%80%A7%E6%8D%9F%E7%9B%8A%E9%A1%B9%E7%9B%AE%E5%8F%8A%E9%87%91%E9%A2%9D) This section details non-recurring gains and losses for the period, totaling **CNY 2.26 million**, primarily from government subsidies and financial asset fair value changes Non-recurring Gains and Losses and Amounts | Item | Amount (CNY) | Explanation | | :--- | :--- | :--- | | Government subsidies recognized in current profit/loss (excluding recurring ones) | 586,829.25 | Mainly various government subsidies received | | Fair value changes and investment income from transactional financial assets | 1,884,210.01 | Fair value changes and investment income from transactional financial assets | | Other non-operating income and expenses apart from the above | 200,653.69 | | | Less: Income tax impact | 405,231.98 | | | Impact on minority interests (after tax) | 10,602.07 | | | **Total** | **2,255,858.90** | | Items Defined as Recurring Gains and Losses | Item | Amount Involved (CNY) | Reason | | :--- | :--- | :--- | | Other income | 405,871.02 | Government subsidies with a continuous impact on company profit/loss | | Other income | 88,354.90 | VAT software tax refund | | Other income | 11,848.12 | Additional VAT input tax deduction | | **Total** | **506,074.04** | | [Management Discussion and Analysis](index=9&type=section&id=%E7%AC%AC%E4%B8%89%E8%8A%82%20%E7%AE%A1%E7%90%86%E5%B1%82%E8%AE%A8%E8%AE%BA%E4%B8%8E%E5%88%86%E6%9E%90) This section provides a comprehensive review of the company's operations, financial performance, and strategic initiatives during the reporting period [Main Business Activities of the Company During the Reporting Period](index=9&type=section&id=%E4%B8%80%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E5%85%AC%E5%8F%B8%E4%BB%8E%E4%BA%8B%E7%9A%84%E4%B8%BB%E8%A6%81%E4%B8%9A%E5%8A%A1) The company focuses on R&D, production, and sales of measurement and testing instruments, actively responding to trade policy changes, investing in overseas production, and innovating with AI in various product lines [Industry Development Overview](index=9&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%E5%85%AC%E5%8F%B8%E6%89%80%E5%8F%84%E8%A1%8C%E4%B8%9A%E5%8F%91%E5%B1%95%E6%83%85%E5%86%B5) The instrument and meter manufacturing industry is rapidly intelligentizing, with China's manufacturing sector globalizing due to US-China tariffs, and domestic high-end instrument demand growing at a **10.11% CAGR** (2023-2030) - In H1 2025, the US imposed multiple rounds of tariffs on Chinese exporters, reaching up to **145%**, resulting in a **27.8% decrease** in China's exports to the US in April-May 2025 compared to the prior year[24](index=24&type=chunk) - Domestic demand for high-end instruments and meters continues to grow, with R&D investment accounting for **2.68% of GDP in 2024**, and the high-end instrument market is projected to grow at a **CAGR of 10.11% from 2023-2030**, reaching **CNY 352.9 billion** by 2030[25](index=25&type=chunk) - Policies are driving the substitution of imported high-end instruments with domestic ones, with government procurement of domestic equipment increasing to **over 50% by 2025** and offering a **20% price deduction**, while special R&D investment from the Ministry of Science and Technology has increased by **150%** compared to the "13th Five-Year Plan" period[26](index=26&type=chunk) [Company's Main Business](index=9&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%E5%85%AC%E5%8F%B8%E4%B8%BB%E8%A6%81%E4%B8%9A%E5%8A%A1) The company expanded its Vietnam production to mitigate tariff risks, launched new products in power quality, solar, ultrasonic thickness, and AI arc detection, and advanced in smart home health, new energy, biomedical, and AI sensing - To mitigate US-China tariff fluctuation risks, the company increased investment in its Vietnam production base, introducing automation, enhancing employee training, and implementing advanced management systems, leading to monthly capacity increases and large-scale product delivery[27](index=27&type=chunk)[28](index=28&type=chunk) - Launched a comprehensive power quality detection solution covering "monitoring-analysis-governance-verification," centered on the **DT-7760 high-end power quality analyzer** and **AI-7760 intelligent power quality analyzer**, empowering new power systems[32](index=32&type=chunk)[33](index=33&type=chunk) - Recently released the **DT-1500PV multi-function photovoltaic I-V curve tester**, integrating I-V curve measurement analysis with power station safety regulation testing to enhance PV plant operation and safety efficiency[35](index=35&type=chunk) - Introduced the **DT-1580 handheld professional ultrasonic thickness gauge**, with a thickness range of **0.08 mm to 635 mm**, suitable for corrosion monitoring, manufacturing quality inspection, and equipment maintenance[37](index=37&type=chunk) - Released a new generation of edge AI arc detection products, including **AFD-80, AFD-74, AFD-60, AFG-1000**, featuring CNN deep learning algorithms with **over 99% fault detection accuracy**, redefining safety standards for solar charging and storage[39](index=39&type=chunk) - Achieved breakthroughs in smart home medical devices, adding **HarmonyOS ecosystem 4G blood pressure monitors (BP-108H, BP-106A)** and the **HX-660 bi-level ventilator**, optimizing product performance with AI large models[41](index=41&type=chunk) - Subsidiary Jiangxi Huashengchang New Energy Technology Co., Ltd. completed its production base construction, establishing a **2 GW annual production capacity** for energy storage products, including industrial/commercial storage, home storage, and DC/AC charging piles[67](index=67&type=chunk)[69](index=69&type=chunk) - Shenzhen Everbest Biomedical Technology Co., Ltd. expanded into IVD in-vitro diagnostics, building two core technology platforms: molecular diagnostics and immunochromatography, with a product matrix covering fully automatic integrated analyzers, real-time fluorescence quantitative PCR analyzers, gold standard AI visual interpretation instruments, and home medical devices[73](index=73&type=chunk)[74](index=74&type=chunk) - Wholly-owned subsidiary Shenzhen Shendu Gancce Technology Co., Ltd. focuses on "AI+sensor" integrated equipment and industrial measurement solutions, co-established the Hunan Provincial Key Laboratory of Energy Artificial Intelligence, and formed a controlling subsidiary focused on AI glasses[75](index=75&type=chunk)[76](index=76&type=chunk) [Analysis of Main Business](index=23&type=section&id=%EF%BC%88%E4%B8%89%EF%BC%89%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%88%86%E6%9E%90) In H1 2025, operating revenue grew **4.91% to CNY 349.40 million**, with net profit (excluding share-based payments) stable, and core high-end product segments growing **13.85%** to **58.00% of revenue** Key Financial Data for Main Business (Jan-Jun 2025) | Indicator | Amount (CNY million) | YoY Growth | | :--- | :--- | :--- | | Operating Revenue | 349.40 | 4.91% | | Net Profit after Share-based Payment Impact | 60.52 | Basically flat | | R&D Expenses | 41.00 | 18.73% | Core Product Segment Revenue and Proportion | Product Segment | Sales Revenue (CNY million) | YoY Growth | Revenue Proportion | | :--- | :--- | :--- | :--- | | Professional Instruments | 157.56 | 12.11% | 45.09% | | Professional Testing Instruments | 40.72 | 16.42% | 11.65% | | Medical Diagnostic Equipment | 4.36 | 76.68% | 1.25% | | **Total for Three Segments** | **202.64** | **13.85%** | **58.00%** | - The company's electrical power products successfully entered domestic power generation-side central state-owned enterprise procurement platforms, gaining authoritative recognition from the national power system[85](index=85&type=chunk) - The **4G blood pressure monitor**, as the world's first HarmonyOS ecosystem blood pressure monitor, successfully entered operator channels, and the **HX-660 bi-level ventilator** achieved large-scale sales[86](index=86&type=chunk) - To counter escalating US-China trade war tariffs, the company increased investment in its Vietnam production base, achieving large-volume shipments in **July 2025**, significantly enhancing its trade competitiveness with the US[88](index=88&type=chunk) - In 2024, the company launched a restricted stock incentive plan and an employee stock ownership plan, granting **1.904 million restricted shares to 155 individuals** and **1.3 million employee shares to 59 individuals**, with **CNY 17.0431 million** in share-based payment expenses recognized this period[89](index=89&type=chunk) [Analysis of Core Competencies](index=25&type=section&id=%E4%BA%8C%E3%80%81%E6%A0%B8%E5%BF%83%E7%AB%9E%E4%BA%89%E5%8A%9B%E5%88%86%E6%9E%90) The company's core competencies include AI-driven product upgrades, a multidisciplinary talent pool, continuous technological advancements, comprehensive technical platforms, a strategic shift to high-end instruments, reliable product quality, and a robust global multi-brand distribution network - The company established a dedicated AI technology department, deeply integrating vertical domain large model technology, AI computing chips, and industry knowledge graphs to create intelligent detection equipment, fostering new quality productive forces[90](index=90&type=chunk) - Possesses a high-caliber, interdisciplinary R&D talent team with an average of **over 10 years of industry experience**, with R&D investment accounting for **11.73% of revenue** in H1 2025[91](index=91&type=chunk) - Continuously achieves breakthroughs in the four core dimensions of "accuracy, reliability, adaptability, and intelligence," building full-chain technological barriers across R&D, manufacturing, and application[92](index=92&type=chunk) - Has established five major technology platforms: power electronics, infrared thermal imaging and temperature measurement, environmental detection, non-destructive testing, and life sciences, making it one of the domestic instrument and meter companies with the most comprehensive measurement technology platforms[93](index=93&type=chunk) - Comprehensive product portfolio covering general instruments, professional instruments, scientific analysis instruments, and life science instruments, gradually advancing into the high-end instrument and meter sector[94](index=94&type=chunk) - Strengthens its global sales network through long-term cooperation with overseas clients, achieving international market coverage across all product lines, and actively cultivating its own brands, "**Huashengchang**" and "**CEM**"[96](index=96&type=chunk)[97](index=97&type=chunk) [Analysis of Main Business](index=26&type=section&id=%E4%B8%89%E3%80%81%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%88%86%E6%9E%90) This section analyzes the company's main business financial performance, noting a **4.91% increase in operating revenue**, an **8.70% rise in operating costs**, and a **67.85% surge in administrative expenses**, while international business revenue grew **8.10%** and medical diagnostic instruments saw **76.68% growth** Key Financial Data Year-over-Year Changes | Indicator | Current Period (CNY) | Prior Year (CNY) | YoY Change | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 349,399,360.85 | 333,050,691.77 | 4.91% | | | Operating Cost | 197,670,081.09 | 181,845,762.62 | 8.70% | | | Selling Expenses | 33,362,658.85 | 30,533,368.44 | 9.27% | | | Administrative Expenses | 32,116,031.81 | 19,133,879.36 | 67.85% | Mainly due to increased share-based payments and human resource investment during the reporting period | | Financial Expenses | -5,059,129.17 | -5,338,266.70 | 5.23% | | | Income Tax Expense | 3,433,897.81 | 5,917,573.55 | -41.97% | Mainly due to a decrease in total profit during the reporting period | | R&D Investment | 40,999,558.41 | 34,532,477.49 | 18.73% | | | Net Cash Flow from Operating Activities | 74,890,850.46 | 83,197,996.78 | -9.98% | | | Net Cash Flow from Investing Activities | 27,194,214.31 | 33,753,970.04 | -19.43% | | | Net Cash Flow from Financing Activities | -127,792,915.06 | -175,196,223.91 | 27.06% | Mainly due to a decrease in cash outflow from financing activities during the reporting period | | Net Increase in Cash and Cash Equivalents | -20,797,965.60 | -57,850,270.68 | 64.05% | Mainly due to a decrease in cash outflow from financing activities during the reporting period | Operating Revenue Composition (by Product) | Product Category | Current Period Amount (CNY) | Proportion of Operating Revenue | Prior Year Amount (CNY) | Proportion of Operating Revenue | YoY Change | | :--- | :--- | :--- | :--- | :--- | :--- | | Professional Instruments | 157,559,444.76 | 45.09% | 140,540,029.99 | 42.20% | 12.11% | | General Instruments | 131,898,004.80 | 37.75% | 132,386,569.92 | 39.75% | -0.37% | | Professional Testing and Scientific Analysis Instruments | 40,715,842.39 | 11.65% | 34,972,286.52 | 10.50% | 16.42% | | Medical Diagnostic and Life Science Analysis Instruments | 4,364,661.45 | 1.25% | 2,470,325.16 | 0.74% | 76.68% | | New Energy Products | 9,017,688.01 | 2.58% | 11,891,389.17 | 3.57% | -24.17% | | Other Businesses | 5,843,719.44 | 1.67% | 10,790,091.01 | 3.24% | -45.84% | Operating Revenue Composition (by Region) | Region | Current Period Amount (CNY) | Proportion of Operating Revenue | Prior Year Amount (CNY) | Proportion of Operating Revenue | YoY Change | | :--- | :--- | :--- | :--- | :--- | :--- | | Domestic | 26,629,695.11 | 7.62% | 29,068,972.39 | 8.73% | -8.39% | | International | 316,925,946.30 | 90.71% | 293,191,628.37 | 88.03% | 8.10% | | Other Businesses | 5,843,719.44 | 1.67% | 10,790,091.01 | 3.24% | -45.84% | Gross Profit Margin Changes for Main Business | Category | YoY Change in Operating Revenue | YoY Change in Operating Cost | YoY Change in Gross Profit Margin | | :--- | :--- | :--- | :--- | | Main Business | 6.61% | 9.72% | -1.61% | | Professional Instruments | 12.11% | 17.51% | -2.44% | | General Instruments | -0.37% | 3.02% | -2.07% | | Professional Testing and Scientific Analysis Instruments | 16.42% | 17.41% | -0.42% | | International Business | 8.10% | 12.14% | -2.07% | [Analysis of Non-Main Business](index=28&type=section&id=%E5%9B%9B%E3%80%81%E9%9D%9E%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%88%86%E6%9E%90) This section analyzes the impact of non-main business activities on total profit, noting positive contributions from investment and fair value changes, but negative impacts from asset and credit impairment losses, with asset impairment being the largest at **-13.72%** Impact of Non-Main Business on Total Profit | Item | Amount (CNY) | Proportion of Total Profit | Reason for Formation | Is it Sustainable | | :--- | :--- | :--- | :--- | :--- | | Investment Income | 733,204.74 | 1.57% | Investment income from disposal of transactional financial assets | No | | Fair Value Change Gains/Losses | 1,151,005.27 | 2.47% | Fair value change gains from transactional financial assets | No | | Asset Impairment | -6,388,386.26 | -13.72% | Provision for inventory impairment based on "Enterprise Accounting Standards" and company accounting policies | No | | Non-operating Income | 249,135.60 | 0.53% | | No | | Non-operating Expenses | 48,481.91 | 0.10% | | No | | Other Income | 1,092,903.29 | 2.35% | Mainly government subsidies | Individual income tax refunds and immediate VAT refunds are sustainable, other government subsidies are not | | Credit Impairment Losses | 2,523,001.65 | 5.42% | Provision for bad debts on receivables based on "Enterprise Accounting Standards" and company accounting policies | No | [Analysis of Assets and Liabilities](index=28&type=section&id=%E4%BA%94%E3%80%81%E8%B5%84%E4%BA%A7%E5%8F%8A%E8%B4%A2%E5%80%BA%E7%8A%B6%E5%86%B5%E5%88%86%E6%9E%90) This section analyzes the company's asset and liability structure and changes, showing a decrease in total assets and net assets attributable to shareholders, with a **4.28% increase in share capital** due to capital reserve conversion Significant Changes in Asset Composition | Item | Current Period End Amount (CNY) | Proportion of Total Assets | Prior Year End Amount (CNY) | Proportion of Total Assets | Proportion Change | Explanation of Significant Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Monetary Funds | 216,591,605.92 | 15.08% | 237,395,625.09 | 15.60% | -0.52% | | | Accounts Receivable | 145,129,469.45 | 10.10% | 198,843,321.04 | 13.07% | -2.97% | | | Inventories | 293,850,036.97 | 20.46% | 285,879,691.52 | 18.79% | 1.67% | | | Long-term Equity Investments | 9,000,000.00 | 0.63% | | | 0.63% | Due to increased equity investments during the reporting period | | Fixed Assets | 89,216,010.03 | 6.21% | 89,184,860.59 | 5.86% | 0.35% | | | Construction in Progress | 286,947,018.86 | 19.98% | 281,675,843.65 | 18.51% | 1.47% | | | Right-of-use Assets | 39,878,355.22 | 2.78% | 32,329,264.39 | 2.13% | 0.65% | | | Short-term Borrowings | 28,947,951.84 | 2.02% | 32,724,696.19 | 2.15% | -0.13% | | | Contract Liabilities | 7,741,223.76 | 0.54% | 8,905,668.76 | 0.59% | -0.05% | | | Long-term Borrowings | 26,446,198.72 | 1.84% | 17,393,493.74 | 1.14% | 0.70% | Due to increased borrowings during the reporting period | | Lease Liabilities | 26,542,514.87 | 1.85% | 21,563,047.39 | 1.42% | 0.43% | | | Prepayments | 28,805,809.08 | 2.01% | 16,529,253.85 | 1.09% | 0.92% | Due to increased material purchases and project prepayments during the reporting period | | Other Non-current Assets | 5,237,724.95 | 0.36% | 3,672,645.65 | 0.24% | 0.12% | Due to increased prepayments for equipment during the reporting period | | Employee Benefits Payable | 14,564,822.21 | 1.01% | 28,875,328.87 | 1.90% | -0.89% | Due to bonus payments during the reporting period | | Non-current Liabilities Due Within One Year | 23,036,656.92 | 1.60% | 13,494,677.53 | 0.89% | 0.71% | Due to increased lease liabilities during the reporting period | | Deferred Income | 2,121,660.40 | 0.15% | 1,039,300.34 | 0.07% | 0.08% | Due to government subsidies related to assets received during the reporting period | | Share Capital | 189,141,160.00 | 13.17% | 135,237,400.00 | 8.89% | 4.28% | Due to conversion of capital reserves into share capital during the reporting period | | Other Comprehensive Income | -1,594,898.47 | -0.11% | -7,730,535.53 | -0.51% | 0.40% | Due to foreign currency translation differences arising from exchange rate fluctuations during the reporting period | Assets and Liabilities Measured at Fair Value | Item | Beginning Balance (CNY) | Fair Value Change Gains/Losses for the Period (CNY) | Amount Purchased This Period (CNY) | Amount Sold This Period (CNY) | Ending Balance (CNY) | | :--- | :--- | :--- | :--- | :--- | :--- | | Transactional Financial Assets | 228,885,280.59 | 1,151,005.27 | 555,000,000.00 | 616,930,350.68 | 168,105,935.18 | | **Total** | **228,885,280.59** | **1,151,005.27** | **555,000,000.00** | **616,930,350.68** | **168,105,935.18** | [Analysis of Investment Status](index=30&type=section&id=%E5%85%AD%E3%80%81%E6%8A%95%E8%B5%84%E7%8A%B6%E5%86%B5%E5%88%86%E6%9E%90) This section summarizes the company's investment activities, with total investments of **CNY 590.60 million**, a **5.58% YoY decrease**, and a **83.26% utilization rate** for raised funds, with some projects delayed or terminated Investment Amount During the Reporting Period | Indicator | Amount (CNY) | Change Rate | | :--- | :--- | :--- | | Investment Amount During the Reporting Period | 590,597,719.84 | -5.58% | | Investment Amount in Prior Year | 625,523,782.57 | | Securities Investment Status | Security Code | Security Abbreviation | Initial Investment Cost (CNY) | Beginning Book Value (CNY) | Fair Value Change Gains/Losses for the Period (CNY) | Ending Book Value (CNY) | | :--- | :--- | :--- | :--- | :--- | :--- | | 002157 | Zhengbang Technology | 692,010.84 | 753,981.96 | -49,060.47 | 704,921.49 | | **Total** | | **692,010.84** | **753,981.96** | **-49,060.47** | **704,921.49** | Overall Utilization of Raised Funds | Fundraising Year | Total Raised Funds (CNY million) | Net Raised Funds (CNY million) | Total Raised Funds Used Cumulatively (CNY million) | Utilization Rate of Raised Funds at Period End | Total Raised Funds with Changed Use Cumulatively (CNY million) | Total Unused Raised Funds (CNY million) | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | 2020 | 496.33 | 454.27 | 378.21 | 83.26% | 196.73 | 76.06 | - The "Huashengchang Instrument and Meter Bazhong Production Base Construction Project" was delayed until **December 31, 2022**, due to objective reasons, and cumulative benefits have not yet met expectations[123](index=123&type=chunk) - The "Headquarters and R&D Center Construction Project" was delayed until **June 30, 2027**, due to high prices and limited availability of suitable office space[123](index=123&type=chunk) - The "Domestic Operations and Marketing Network Construction Project" has been terminated, with remaining raised funds reallocated to the "Huashengchang Intelligent Sensing Measurement Instrument R&D and Production Project"[123](index=123&type=chunk) - The "Huashengchang Intelligent Sensing Measurement Instrument R&D and Production Project" has completed its committed investment using raised funds, with subsequent investments to be made from own funds or other financing methods[124](index=124&type=chunk) [Significant Asset and Equity Sales](index=35&type=section&id=%E4%B8%83%E3%80%81%E9%87%8D%E5%A4%A7%E8%B5%84%E4%BA%A7%E5%92%8C%E8%82%A1%E6%9D%83%E5%87%BA%E5%94%AE) This section states that the company did not engage in any significant asset or equity sales during the reporting period - The company did not sell significant assets during the reporting period[127](index=127&type=chunk) - The company did not sell significant equity during the reporting period[128](index=128&type=chunk) [Analysis of Major Holding and Participating Companies](index=36&type=section&id=%E5%85%AB%E3%80%81%E4%B8%BB%E8%A6%81%E6%8E%A7%E8%82%A1%E5%8F%82%E8%82%A1%E5%85%AC%E5%8F%B8%E5%88%86%E6%9E%90) This section lists the company's acquisitions and disposals of subsidiaries during the reporting period, including the establishment of Hunan Huazhihong, Shenzhen Everbest Import & Export, Shenzhen Shendu Gancce, and Shenzhen Shenjing Zhinen Acquisition and Disposal of Subsidiaries During the Reporting Period | Company Name | Method of Acquisition/Disposal of Subsidiaries During the Reporting Period | Impact on Overall Production, Operations, and Performance | | :--- | :--- | :--- | | Hunan Huazhihong Intelligent Technology Co., Ltd. | Newly established | | | Shenzhen Everbest Import & Export Trading Co., Ltd. | Newly established | | | Shenzhen Shendu Gancce Technology Co., Ltd. | Newly established | | | Shenzhen Shenjing Zhinen Technology Co., Ltd. | Newly established, invested by Shenzhen Shendu Gancce Technology Co., Ltd. | | [Information on Structured Entities Controlled by the Company](index=36&type=section&id=%E4%B9%9D%E3%80%81%E5%85%AC%E5%8F%B8%E6%8E%A7%E5%88%B6%E7%9A%84%E7%BB%93%E6%9E%84%E5%8C%96%E4%B8%BB%E4%BD%93%E6%83%85%E5%86%B5) This section states that the company did not control any structured entities during the reporting period - The company did not control any structured entities during the reporting period[129](index=129&type=chunk) [Risks Faced by the Company and Countermeasures](index=36&type=section&id=%E5%8D%81%E3%80%81%E5%85%AC%E5%8F%B8%E9%9D%A2%E4%B8%B4%E7%9A%84%E9%A3%8E%E9%99%A9%E5%92%8C%E5%BA%94%E5%AF%B9%E6%8E%AA%E6%96%BD) The company addresses risks from international trade policies, exchange rate fluctuations, raw material prices, and market competition by monitoring policies, expanding market share, optimizing supply chains, and enhancing product value and quality - International trade policy and exchange rate fluctuation risks: The company's overseas business is significantly affected by international trade policies and business environments, with exchange rate fluctuations creating uncertainty for operating performance[129](index=129&type=chunk) - Countermeasures: Closely monitor policy changes, increase market share in emerging countries and the domestic market, enhance product value, improve financial and foreign exchange business capabilities, and mitigate exchange rate fluctuation risks through financial instruments[130](index=130&type=chunk) - Raw material price fluctuation risk: Rising upstream raw material prices may adversely affect product manufacturing costs[131](index=131&type=chunk) - Countermeasures: Optimize supply chain resources, rationally plan material procurement and inventory, and reduce costs through technological upgrades, strict cost control, and enhanced economies of scale[131](index=131&type=chunk) - Market competition risk: The instrument and meter industry is highly competitive with numerous similar enterprises[132](index=132&type=chunk) - Countermeasures: Closely monitor market policy changes, promptly adjust business strategies, continuously explore new markets, and consistently improve product quality, technical levels, and management efficiency to maintain customer loyalty[133](index=133&type=chunk) [Formulation and Implementation of Market Value Management System and Valuation Enhancement Plan](index=37&type=section&id=%E5%8D%81%E4%B8%80%E3%80%81%E5%B8%82%E5%80%BC%E7%AE%A1%E7%90%86%E5%88%B6%E5%BA%A6%E5%92%8C%E4%BC%B0%E5%80%BC%E6%8F%90%E5%8D%87%E8%AE%A1%E5%88%92%E7%9A%84%E5%88%B6%E5%AE%9A%E8%90%BD%E5%AE%9E%E6%83%85%E5%86%B5) This section states that the company has not formulated a market value management system or disclosed a valuation enhancement plan - The company has not formulated a market value management system[134](index=134&type=chunk) - The company has not disclosed a valuation enhancement plan[134](index=134&type=chunk) [Implementation of "Quality and Return Dual Enhancement" Action Plan](index=37&type=section&id=%E5%8D%81%E4%BA%8C%E3%80%81%22%E8%B4%A8%E9%87%8F%E5%9B%9E%E6%8A%A5%E5%8F%8C%E6%8F%90%E5%8D%87%22%E8%A1%8C%E5%8A%A8%E6%96%B9%E6%A1%88%E8%B4%AF%E5%BD%BB%E8%90%BD%E5%AE%9E%E6%83%85%E5%86%B5) This section states that the company has not disclosed an announcement regarding the "Quality and Return Dual Enhancement" action plan - The company has not disclosed an announcement regarding the "Quality and Return Dual Enhancement" action plan[134](index=134&type=chunk) [Corporate Governance, Environment, and Society](index=38&type=section&id=%E7%AC%AC%E5%9B%9B%E8%8A%82%20%E5%85%AC%E5%8F%B8%E6%B2%BB%E7%90%86%E3%80%81%E7%8E%AF%E5%A2%83%E5%92%8C%E7%A4%BE%E4%BC%9A) This section covers changes in company leadership, profit distribution, employee incentives, environmental disclosures, and social responsibility initiatives [Changes in Directors, Supervisors, and Senior Management](index=38&type=section&id=%E4%B8%80%E3%80%81%E5%85%AC%E5%8F%B8%E8%91%A3%E4%BA%8B%E3%80%81%E7%9B%91%E4%BA%8B%E3%80%81%E9%AB%98%E7%BA%A7%E7%AE%A1%E7%90%86%E4%BA%BA%E5%91%98%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) This section states that there were no changes in the company's directors, supervisors, or senior management during the reporting period - There were no changes in the company's directors, supervisors, and senior management during the reporting period, as detailed in the 2024 annual report[136](index=136&type=chunk) [Profit Distribution and Capital Reserve Conversion to Share Capital in This Reporting Period](index=38&type=section&id=%E4%BA%8C%E3%80%81%E6%9C%AC%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%88%A9%E6%B6%A6%E5%88%86%E9%85%8D%E5%8F%8A%E8%B5%84%E6%9C%AC%E5%85%AC%E7%A7%AF%E9%87%91%E8%BD%AC%E5%A2%9E%E8%82%A1%E6%9C%AC%E6%83%85%E5%86%B5) This section states that the company plans no cash dividends, bonus shares, or capital reserve conversions to share capital for the semi-annual period - The company plans not to distribute cash dividends, bonus shares, or convert capital reserves into share capital for the semi-annual period[137](index=137&type=chunk) [Implementation of Company Equity Incentive Plans, Employee Stock Ownership Plans, or Other Employee Incentive Measures](index=38&type=section&id=%E4%B8%89%E3%80%81%E5%85%AC%E5%8F%B8%E8%82%A1%E6%B1%83%E6%BF%80%E5%8A%B1%E8%AE%A1%E5%88%92%E3%80%81%E5%91%98%E5%B7%A5%E6%8C%81%E8%82%A1%E8%AE%A1%E5%88%92%E6%88%96%E5%85%B6%E4%BB%96%E5%91%98%E5%B7%A5%E6%BF%80%E5%8A%B1%E6%8E%AA%E6%96%BD%E7%9A%84%E5%AE%9E%E6%96%BD%E6%83%85%E5%86%B5) The company implemented a 2024 restricted stock incentive plan, granting **1,904,000 shares to 155 individuals**, and an employee stock ownership plan holding **1,820,000 shares (0.96% of total share capital)**, establishing long-term incentive mechanisms - The 2024 Restricted Stock Incentive Plan has completed its initial grant registration, with **1,904,000 shares** initially granted[140](index=140&type=chunk) - The 2024 Employee Stock Ownership Plan holds a total of **1,820,000 shares**, accounting for **0.96%** of the listed company's total share capital[142](index=142&type=chunk) - The funding sources for the employee stock ownership plan include employees' legal remuneration, self-raised funds, and other methods permitted by laws and regulations[142](index=142&type=chunk) - During the reporting period, the company's 2024 annual profit distribution and capital reserve conversion to share capital were completed, and the number of shares held by each participant in the employee stock ownership plan increased accordingly[142](index=142&type=chunk) [Environmental Information Disclosure](index=40&type=section&id=%E5%9B%9B%E3%80%81%E7%8E%AF%E5%A2%83%E4%BF%A1%E6%81%AF%E6%8A%AB%E9%9C%B2%E6%83%85%E5%86%B5) This section states that the listed company and its main subsidiaries are not included in the list of enterprises required to disclose environmental information by law - The listed company and its main subsidiaries are not included in the list of enterprises required to disclose environmental information by law[144](index=144&type=chunk) [Social Responsibility](index=40&type=section&id=%E4%BA%94%E3%80%81%E7%A4%BE%E4%BC%9A%E8%B4%A3%E4%BB%BB%E6%83%85%E5%86%B5) The company actively fulfills its social responsibilities by enhancing corporate governance, protecting shareholder and employee rights, fostering talent, and building strategic partnerships with customers and suppliers for mutual benefit - The company strictly adheres to laws and regulations, improves its corporate governance structure, safeguards the legitimate rights and interests of shareholders, especially minority shareholders, and ensures timely, truthful, accurate, and complete information disclosure[145](index=145&type=chunk) - The company adheres to a people-oriented approach, strictly implements national employment, labor protection, and social security systems, and prioritizes employee career development planning and talent cultivation[146](index=146&type=chunk) - The company values communication and coordination with customers and suppliers, establishing strategic partnerships to share information, promote technological exchange and progress, and maximize mutual benefits[147](index=147&type=chunk) [Significant Matters](index=41&type=section&id=%E7%AC%AC%E4%BA%94%E8%8A%82%20%E9%87%8D%E8%A6%81%E4%BA%8B%E9%A1%B9) This section details various important events, including shareholder commitments, related party transactions, legal proceedings, and other material disclosures [Commitments Fulfilled and Unfulfilled by Actual Controller, Shareholders, Related Parties, Acquirers, and the Company During and as of the End of the Reporting Period](index=41&type=section&id=%E4%B8%80%E3%80%81%E5%85%AC%E5%8F%B8%E5%AE%9E%E9%99%85%E6%8E%A7%E5%88%B6%E4%BA%BA%E3%80%81%E8%82%A1%E4%B8%9C%E3%80%81%E5%85%B3%E8%81%94%E6%96%B9%E3%80%81%E6%94%B6%E8%B4%AD%E4%BA%BA%E4%BB%A5%E5%8F%8A%E5%85%AC%E5%8F%B8%E7%AD%89%E6%89%BF%E8%AF%BA%E7%9B%B8%E5%85%B3%E6%96%B9%E5%9C%A8%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E5%B1%A5%E8%A1%8C%E5%AE%8C%E6%AF%95%E5%8F%8A%E6%88%AA%E8%87%B3%E6%8A%A5%E5%91%8A%E6%9C%AB%E8%B6%85%E6%9C%9F%E6%9C%AA%E5%B1%A5%E8%A1%8C%E5%AE%8C%E6%AF%95%E7%9A%84%E6%89%BF%E8%AF%BA%E4%BA%8B%E9%A1%B9) This section confirms that share reduction commitments made by the company's actual controller, shareholders, and related parties during IPO or refinancing have been fulfilled on time, with no overdue unfulfilled commitments at period-end - The share reduction commitments made by the company's controlling shareholder, actual controller, Chairman and General Manager Yuan Jianmin, company shareholder, Vice Chairman and Deputy General Manager Che Haixia, and company shareholders Huaju Enterprise, Huahang Enterprise, and Zhiyi Investment during the initial public offering have been fulfilled on time[149](index=149&type=chunk) - The commitment period was within two years after the lock-up period expired[149](index=149&type=chunk) [Non-operating Fund Occupation by Controlling Shareholder and Other Related Parties of the Listed Company](index=41&type=section&id=%E4%BA%8C%E3%80%81%E6%8E%A7%E8%82%A1%E8%82%A1%E4%B8%9C%E5%8F%8A%E5%85%B6%E4%BB%96%E5%85%B3%E8%81%94%E6%96%B9%E5%AF%B9%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E7%9A%84%E9%9D%9E%E7%BB%8F%E8%90%A5%E6%80%A7%E5%8D%A0%E7%94%A8%E8%B5%84%E9%87%91%E6%83%85%E5%86%B5) This section states that there was no non-operating fund occupation by the controlling shareholder or other related parties of the listed company during the reporting period - During the reporting period, there was no non-operating fund occupation by the controlling shareholder or other related parties of the listed company[150](index=150&type=chunk) [Illegal External Guarantees](index=41&type=section&id=%E4%B8%89%E3%80%81%E8%BF%9D%E8%A7%84%E5%AF%B9%E5%A4%96%E6%8B%85%E4%BF%9D%E6%83%85%E5%86%B5) This section states that the company had no illegal external guarantees during the reporting period - The company had no illegal external guarantees during the reporting period[151](index=151&type=chunk) [Appointment and Dismissal of Accounting Firms](index=41&type=section&id=%E5%9B%9B%E3%80%81%E8%81%98%E4%BB%BB%E3%80%81%E8%A7%A3%E8%81%98%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%83%85%E5%86%B5) This section states that the company's semi-annual report was not audited - The company's semi-annual report was not audited[152](index=152&type=chunk) [Explanation by the Board of Directors and Supervisory Board on the Accounting Firm's "Non-Standard Audit Report" for This Period](index=41&type=section&id=%E4%BA%94%E3%80%81%E8%91%A3%E4%BA%8B%E4%BC%9A%E3%80%81%E7%9B%91%E4%BA%8B%E4%BC%9A%E5%AF%B9%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%9C%AC%E6%8A%A5%E5%91%8A%E6%9C%9F%22%E9%9D%9E%E6%A0%87%E5%87%86%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A%22%E7%9A%84%E8%AF%B4%E6%98%8E) This section states that there is no explanation from the Board of Directors or Supervisory Board regarding a "non-standard audit report" for this period - During the reporting period, there was no explanation from the Board of Directors or Supervisory Board regarding a "non-standard audit report" from the accounting firm for this period[153](index=153&type=chunk) [Explanation by the Board of Directors on Matters Related to the Prior Year's "Non-Standard Audit Report"](index=41&type=section&id=%E5%85%AD%E3%80%81%E8%91%A3%E4%BA%8B%E4%BC%9A%E5%AF%B9%E4%B8%8A%E5%B9%B4%E5%BA%A6%22%E9%9D%9E%E6%A0%87%E5%87%86%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A%22%E7%9B%B8%E5%85%B3%E6%83%85%E5%86%B5%E7%9A%84%E8%AF%B4%E6%98%8E) This section states that there is no explanation from the Board of Directors regarding matters related to the prior year's "non-standard audit report" - During the reporting period, there was no explanation from the Board of Directors regarding matters related to the prior year's "non-standard audit report"[153](index=153&type=chunk) [Bankruptcy and Reorganization Matters](index=42&type=section&id=%E4%B8%83%E3%80%81%E7%A0%B4%E4%BA%A7%E9%87%8D%E6%95%B4%E7%9B%B8%E5%85%B3%E4%BA%8B%E9%A1%B9) This section states that the company had no bankruptcy and reorganization matters during the reporting period - The company had no bankruptcy and reorganization matters during the reporting period[154](index=154&type=chunk) [Litigation Matters](index=42&type=section&id=%E5%85%AB%E3%80%81%E8%AF%89%E8%AE%BC%E4%BA%8B%E9%A1%B9) This section discloses the company's litigation matters, with no major lawsuits, but minor cases as defendant (CNY 0.91 million) and plaintiff (CNY 5.60 million), neither having a significant impact - The company had no significant litigation or arbitration matters during this reporting period[155](index=155&type=chunk) Other Litigation Matters | Basic Information on Litigation (Arbitration) | Amount Involved (CNY million) | Whether a Provision for Liabilities is Formed | Litigation (Arbitration) Progress | Impact of Litigation (Arbitration) | | :--- | :--- | :--- | :--- | :--- | | Litigation where

Group 1 - As of August 22, 2025, the stock price of Huashengchang is 25.78 yuan, down 0.12 yuan or 0.46% from the previous trading day [1] - The opening price on the same day was 25.93 yuan, with a highest price of 27.05 yuan and a lowest price of 25.70 yuan, resulting in a fluctuation of 5.21% [1] - The total trading volume for the day was 115,600 hands, with a total transaction amount of 302 million yuan [1] Group 2 - Huashengchang operates in the instrument manufacturing industry, focusing on the research, development, production, and sales of testing and measuring instruments [1] - The company's products are primarily used in the power, electronics, and manufacturing sectors [1] - Huashengchang is registered in Shenzhen, Guangdong Province [1] Group 3 - On August 22, the net inflow of main funds was 17.71 million yuan, with a cumulative net inflow of 50.71 million yuan over the past five trading days [1] - The current total market capitalization of the company is 4.876 billion yuan, while the circulating market capitalization is 2.588 billion yuan [1]

Group 1 - The stock price of Huashengchang closed at 25.90 yuan on August 21, down 1.07 yuan, a decrease of 3.97% from the previous trading day [1] - The stock reached a high of 27.45 yuan and a low of 25.74 yuan during the day, with a total trading volume of 3.09 billion yuan and a turnover rate of 11.69% [1] - The company specializes in the research, development, production, and sales of testing and measurement instruments, primarily used in the power, electronics, and automotive manufacturing sectors [1] Group 2 - On the morning of August 21, Huashengchang experienced a rapid decline, with the stock price reported at 26.53 yuan at 9:36 AM, down 1.74% from the opening price, and a drop of over 2% within 5 minutes, with a trading volume of 79.17 million yuan during that period [1] - Data on capital flow indicated a net outflow of 26.16 million yuan from main funds on August 21, accounting for 1.01% of the circulating market value [1] - Over the past five trading days, there has been a cumulative net inflow of 27.27 million yuan from main funds, representing 1.05% of the circulating market value [1]

Market Performance - The grid equipment sector rose by 0.59% compared to the previous trading day, with N Hongyuan leading the gains [1] - The Shanghai Composite Index closed at 3766.21, up 1.04%, while the Shenzhen Component Index closed at 11926.74, up 0.89% [1] Stock Highlights - N Hongyuan's closing price was 42.00, with a significant increase of 358.02% and a trading volume of 274,300 shares, amounting to 1.11 billion yuan [1] - Other notable stocks included: - Songsheng Co., Ltd. at 26.98, up 12.42% [1] - RIFENG at 12.61, up 10.03% [1] - Huashengchang at 26.97, up 9.99% [1] - Sanbian Technology at 14.70, up 4.78% [1] Capital Flow - The grid equipment sector experienced a net outflow of 642 million yuan from institutional investors, while retail investors saw a net inflow of 692 million yuan [2] - The capital flow for specific stocks showed: - Huashengchang had a net inflow of 75.2 million yuan from institutional investors [3] - RIFENG had a net inflow of 72.8 million yuan from institutional investors [3] - Sanbian Technology had a net inflow of 64.2 million yuan from institutional investors [3]

截至8月7日收盘，血氧仪概念上涨1.62%，位居概念板块涨幅第5，板块内，15股上涨，晶华微、爱朋 医疗、宝莱特等涨幅居前，分别上涨14.41%、8.45%、3.51%。跌幅居前的有华盛昌、长虹美菱、红日 药业等，分别下跌2.11%、0.82%、0.72%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 稀土永磁 | 3.24 | 减肥药 | -1.70 | | 脑机接口 | 2.69 | CRO概念 | -1.66 | | 高压氧舱 | 2.56 | 创新药 | -1.41 | | 太赫兹 | 1.65 | 仿制药一致性评价 | -1.34 | | 血氧仪 | 1.62 | 重组蛋白 | -1.29 | | 存储芯片 | 1.40 | 中船系 | -1.28 | | MCU芯片 | 1.18 | 阿尔茨海默概念 | -1.18 | | 无线耳机 | 1.08 | 特钢概念 | -1.02 | | 汽车芯片 | 1.02 | 细胞免疫治疗 | -1.02 | | DRG/DIP | 1.00 | PET铜箔 ...

证券之星消息，8月4日电网设备板块较上一交易日上涨0.81%，长城电工领涨。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。电网设备板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 600192 | 长城电工 | 10.86 | 10.03% | 43.73万 | | 4.65亿 | | 000533 | 顺钢股份 | 7.68 | 10.03% | 151.04万 | | 11.30亿 | | 002980 | 华盛昌 | 23.87 | 10.00% | C 11.41万 | | 2.64亿 | | 300853 | 申昊科技 | 26.31 | 7.21% | 18.65万 | | 4.82亿 | | 301120 | 新特电气 | 12.89 | 6.79% | 39.82万 | | 5.02亿 | | 920037 | 广信科技 | 83.57 | 6.12% | 5.47万 | | 4.55亿 | ...